Skip to main content

Table 2 Relation between SATB2-AS1 expression and clinicopathological characteristics of BC patients

From: RETRACTED ARTICLE: Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like

Clinicopathological characteristics

n

SATB2-AS1 expression

P

Low expression (n = 66)

High expression (n = 65)

Age (year)

   

0.379

 ≥ 51

55

25

30

 

 < 51

76

41

35

 

Menopause

   

0.862

 No

61

30

31

 

 Yes

70

36

34

 

LNM

   

0.002

 No

58

20

38

 

 Yes

73

46

27

 

Tumor diameter

   

0.003

 < 2 cm

46

15

31

 

 ≥ 2 cm

85

51

34

 

TNM stage

   

0.008

 I–II

73

29

44

 

 III–IV

58

37

21

 

Histological grade

   

0.138

 G1

27

11

16

 

 G2

68

38

30

 

 G3

36

17

19

 

Estrogen receptor

 +

58

23

35

0.029

 –

73

43

30

 

Progesterone receptor

 +

61

24

37

0.018

 –

70

42

28

 

HER2 status

 –

72

47

35

0.337

 +

59

29

30

 
  1. BC breast cancer, SATB2-AS1 antisense transcript of SATB2 protein, LNM lymph node metastasis, TNM tumor, node and metastasis